Latest Share Chat

Ekf Diagnostics Share News (EKF)

Ekf Diagnostics Information

Buy EKF Shares
Add EKF to Watchlist
Add EKF to Alert

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 27.60

Bid: 27.80

Ask: 28.60

Change: -0.45 (-1.57%)

Spread: 0.80 (2.878%)

Open: 27.60

High: 27.60

Low: 27.60

Prev. Close: 28.65

Last checked at -

IN BRIEF: EKF Diagnostics reports trading in line with expectations

Wed, 17th May 2023 17:26

EKF Diagnostics Holdings PLC - Penarth, Wales-based diagnostics company - Chair Julian Baines notes an "encouraging" set of results for 2022 in his annual general meeting statement, with revenue in-line with market expectations thanks to "strong" growth in its Point of Care and Life Sciences businesses. Adds that trading in the first quarter of 2023 has also been in-line with expectations. Says that with the anticipated contribution from its expanded Life Sciences capacity coming online over the second half of the year, it expects its financial performance to be more second-half-weighted in 2023 than it has been historically. Expects continued growth from its "razor, razor blade" consumable model in Point of Care to add to the positive momentum."

Current stock price: 24.70 pence

12-month change: down 29%

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

More News

22 May 2014 08:34

Thursday broker round-up UPDATE

ASOS: Goldman Sachs reduces target price from 7300p to 6250p, while upgrading to buy. BTG: N+1 Singer shaves target price from 488p to 486p retaining a sell recommendation. EKF Diagnostics: FinnCap initiates with a target price of 38p and a buy recommendation. Exova Group: Credit Suisse starts wi

20 May 2014 10:08

EKF Diagnostics Subsidiary Signs US Testing Deal As Firm Trades In Line

LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Tuesday its wholly-owned subsidiary, Selah Genomics Inc, has signed a agreement with a US sales firm to provide testing services for a new suite of womaen's health-focused molecular assays. The AIM-listed point-of-care, central labo

20 May 2014 07:24

UK MORNING BRIEFING: M&A Takes Back Centre Stage

LONDON (Alliance News) - Company acquisitions and disposals have roared back to the fore Tuesday, with RSA Insurance, London Stock Exchange, Wolseley, RPS, Cobham and others all making pre-market announcements

15 May 2014 10:22

DIRECTOR DEALINGS: EKF Executive Buys 91,000 Shares

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said Michael Bolick, a divisional executive bought 91,00 shares at a price of 27.04 pence per share Monday. Following this transaction, Bolick now holds 5 million shares, which represents 1.17% stake in the firm. Shares in

8 May 2014 13:31

DIRECTOR DEALINGS: EKF Directors, Non-Executives Buy Shares

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said a group of Directors and non-executives bought shares in the central laboratory and molecular diagnostics business.

Details are as follows.

7 May 2014 13:10

UK MIDDAY BRIEFING: HSBC Profit Slides, Sainsbury Holding Out

LONDON (Alliance News) - HSBC Holdings Wednesday reported a 20% drop in first-quarter pretax profit, driven by a weak performance Asia, Latin America and its investment bank, that was only partially offset by lower impairment charges and continued cost cutting.

In a

7 May 2014 12:12

UPDATE: EKF Diagnostics Drops As Medicare Reimbursement For Selah Biomarkers Reduced

LONDON (Alliance News) - EKF Diagnostics Holdings PLC saw its shares drop on the AIM All-Share market Wednesday after the company said reimbursement by Medicare for Selah Genomic's drug metabolism genetic biomarkers panel, has been reduced after revisions by the Medicare Administrative Contractor

7 May 2014 12:07

UK WINNERS & LOSERS: Legal & General Leads On Confidence In Annuities

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 - WINNERS
-------
Legal & General Group, up 3.2%. The group said it expects to write more

7 May 2014 09:19

EKF Diagnostics Drops As Medicare Reimbursement For DME Reduced

LONDON (Alliance News) - EKF Diagnostics Holdings PLC saw its shares drop on the AIM All-Share market Wednesday morning as the company said reimbursement by Medicare for Selah Genomic's DME panel, has been reduced after revisions by the MAC. The point-of-care, central laboratory and molecul

7 May 2014 09:06

UK BROKER RATINGS: UBS Raises Balfour Beatty As Jefferies Cuts

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS PT TO 2100 (1900) PENCE - 'EQUAL WEIGHT
----------
CREDIT SUISSE RAISES IN

7 May 2014 08:35

Wednesday broker round-up UPDATE

Balfour Beatty: Jefferies reduces target price from 403p to 233p downgrading to hold. Deutsche Bank cuts target price from 280p to 250p and leaves its hold recommendation unchanged. Numis reduces target price to 260p and retains an add rating. Barclays: Deutsche Bank lowers target price from 320p t

10 Apr 2014 09:56

EKF Diagonostics Raises GBP4 Million In Oversubscribed Share Offer

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said that it had raised GBP4.0 million, before expenses, in an oversubscribed share offer. Last month, the company said it raised GBP22.0 million in a placing at 35 pence a share and said it was also looking to raise an addition

26 Mar 2014 15:54

Carnival Chairman reduces stake by around a quarter

Micky Arison, the long-standing Chairman of cruise line operator Carnival Corp., docked a batch of shares earlier this week ahead of its better-than-expected first quarter trading update. Arison offloaded 525,348 at $40.09 each, reducing his stake to 104.52m shares. The group on Tuesday reported

20 Mar 2014 11:46

EKF Diagnostics Raises Funds In Placing As It Announces Acquisitions

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said it has entered into separate conditional agreements to buy US-based molecular diagnostics business Selah Genomics Inc for up to USD70.6 million and Swedish haemoglobin analysers DiaSpect Medical AB for up to GBP20.75 million.

20 Mar 2014 11:10

EKF Diagnostics proposes acquisition of Selah Genomics and DiaSpect Medical

EKF Diagnostics has entered into conditional agreements to buy US-based Selah Genomics and Swiss firm DiaSpect Medical. The company has proposed raising £22m through the placement of 14,285,714 new ordinary shares and a conditional placing of 48,571,428 new ordinary shares at a placing price of 35p

Latest Share Chat

Ekf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: EKF Diagnostics reports trading in line with expectations

Login to your account

Quickpicks are a member only feature

Login to your account